» Articles » PMID: 28952896

Gastrointestinal Prophylaxis in Sports Medicine

Overview
Journal Sports Health
Publisher Sage Publications
Specialty Orthopedics
Date 2017 Sep 28
PMID 28952896
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Because sports participation at all levels often requires international travel, coaches, athletic trainers, and team physicians must effectively protect athletes from gastrointestinal infections. Traveler's diarrhea is the most common travel-related illness and can significantly interfere with training and performance.

Evidence Acquisition: A review of relevant publications was completed using PubMed and Google Scholar.

Study Design: Clinical review.

Level Of Evidence: Level 5 Results: Enterotoxigenic and enteroaggregative Escherichia coli are the most common bacterial causes of traveler's diarrhea. Traveler's diarrhea generally occurs within 4 days of arrival, and symptoms tend to resolve within 5 days of onset. There are several prophylactic agents that physicians can recommend to athletes, including antibiotics, bismuth subsalicylate, and probiotics; however, each has its own unique limitations. Decision-making should be based on the athlete's destination, length of stay, and intent of travel.

Conclusion: Prophylaxis with antibiotics is highly effective; however, physicians should be hesitant to prescribe medication due to the side effects and risks for creating antibiotic-resistant bacterial strains. Antibiotics may be indicated for high-risk groups, such as those with a baseline disease or travelers who have little flexible time. Since most cases of traveler's diarrhea are caused by food and/or water contamination, all athletes should be educated on the appropriate food and water consumption safety measures prior to travel.

Citing Articles

Use of nanoparticles, a modern means of drug delivery, against cryptosporidiosis.

AlFaleh F, Ismael S, Aguilar-Marcelino L, Silva F, Ashraf T, Abbas R J Adv Vet Anim Res. 2024; 10(4):704-719.

PMID: 38370897 PMC: 10868694. DOI: 10.5455/javar.2023.j726.


Microbial bowel infections-induced biochemical and biological abnormalities and their effects on young Egyptian swimmers.

Hassanein F, Masoud I, Awwad Z, Abdel-Salam H, Salem M, Shehata A Sci Rep. 2023; 13(1):4597.

PMID: 36944683 PMC: 10030829. DOI: 10.1038/s41598-023-31708-3.

References
1.
Widdowson M, Monroe S, Glass R . Are noroviruses emerging?. Emerg Infect Dis. 2005; 11(5):735-7. PMC: 3320389. DOI: 10.3201/eid1105.041090. View

2.
Alajbegovic S, Sanders J, Atherly D, Riddle M . Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis. Syst Rev. 2012; 1:39. PMC: 3441921. DOI: 10.1186/2046-4053-1-39. View

3.
Ericsson C . Travellers' diarrhoea. Int J Antimicrob Agents. 2003; 21(2):116-24. DOI: 10.1016/s0924-8579(02)00282-0. View

4.
Zanger P, Nurjadi D, Gabor J, Gaile M, Kremsner P . Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2013; 13(11):946-54. DOI: 10.1016/S1473-3099(13)70221-4. View

5.
Huang D, Sanchez A, Triana E, Jiang Z, DuPont H, Ericsson C . United States male students who heavily consume alcohol in Mexico are at greater risk of travelers' diarrhea than their female counterparts. J Travel Med. 2005; 11(3):143-5. DOI: 10.2310/7060.2004.18560. View